Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...

Q4 2024 Earnings Call Transcript February 7, 2025 Operator: Ladies and gentlemen, thank you for standing by. Welcome to ...

For businesses interested in having a unit installed, if you’d like Narcan kits dropped off at your business, or if you’d ...

After passing some regulations in 2024, Iowa state lawmakers are this year once again considering legislation that would further regulate pharmacy benefit managers — or PBMs.

The bill would allow pharmacies to decline dispensing prescriptions to people if that pharmacy would be reimbursed less than ...

The Bay State Banner's Breje Williams joins Jennifer Eagan and Rhondella Richardson to discuss the pilot program taking shape ...

Blue Trust Inc. lessened its stake in Silgan Holdings Inc. (NYSE:SLGN – Free Report) by 16.6% in the fourth quarter, Holdings ...

DES MOINES, Iowa– The Iowa Pharmacy Association is praising the introduction of legislation aimed at reforming Pharmacy ...

Silgan (NYSE:SLGN – Free Report) had its target price boosted by Raymond James from $62.00 to $65.00 in a research report ...

Q4 2024 Earnings Call Transcript January 29, 2025 Silgan Holdings Inc. beats earnings expectations. Reported EPS is $0.85, expectations were $0.82. Operator: Good day, and welcome to the Silgan ...

Wells Fargo analyst Gabrial Hajde has reiterated their bullish stance on SLGN stock, giving a Buy rating on January 23.Invest with Confidence: ...

Management provided an adjusted EPS estimate for 2025 in the range of $4 to $4.20, representing a 13% increase at the midpoint compared to $3.62 in 2024. Free cash flow is projected at approximately ...